Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis

被引:50
作者
Jabs, DA
Martin, BK
Forman, MS
Dunn, JP
Davis, JL
Weinberg, DV
Biron, KK
Baldanti, F
机构
[1] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[4] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[5] Univ Miami, Dept Ophthalmol, Miami, FL 33152 USA
[6] Northwestern Univ, Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA
[7] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
[8] Policlin San Matteo, Inst Ricovero & Cura Carattere Sci, Serv Virol, I-27100 Pavia, Italy
关键词
D O I
10.1086/317931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytomegalovirus (CMV) retinitis is among the most common opportunistic infections in patients with acquired immunodeficiency syndrome. In a prospective study of 210 patients with CMV retinitis, 26 were identified as having either a phenotypic or a genotypic ganciclovir-resistant isolate from either blood or urine cultures. For blood culture isolates with an IC50 >6.0 mum for ganciclovir, the sensitivity and specificity for detecting a UL97 mutation were 95% and 98%, respectively, whereas for an IC50 >8.0 muM they were 79% and 99%, respectively. Although there were trade- offs between the 2 thresholds for blood culture isolates, for urine culture isolates an IC50 >8.0 muM appeared to be better at identifying genotypic resistance. UL97 mutations identified in both the blood and urine cultures of individual patients were identical in 87.5% of cases. High- level ganciclovir resistance (IC50, >30 muM) typically, but not invariably, was associated with a mutation in both the UL97 and UL54 genes.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 18 条
[1]   Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood [J].
Baldanti, F ;
Simoncini, L ;
Sarasini, A ;
Zavattoni, M ;
Grossi, P ;
Revell, MG ;
Gerna, G .
TRANSPLANTATION, 1998, 66 (03) :324-329
[2]   Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance [J].
Chou, SW ;
Lurain, NS ;
Weinberg, A ;
Cai, GY ;
Sharma, PL ;
Crumpacker, CS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1500-1502
[3]   FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES [J].
CHOU, SW ;
GUENTZEL, S ;
MICHELS, KR ;
MINER, RC ;
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :239-242
[4]   Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[5]   ANALYSIS OF THE UL97 PHOSPHOTRANSFERASE CODING SEQUENCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES AND IDENTIFICATION OF MUTATIONS CONFERRING GANCICLOVIR RESISTANCE [J].
CHOU, SW ;
ERICE, A ;
JORDAN, MC ;
VERCELLOTTI, GM ;
MICHELS, KR ;
TALARICO, CL ;
STANAT, SC ;
BIRON, KK .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :576-583
[6]   IDENTIFICATION OF MULTIPLE STRAINS OF CYTOMEGALO-VIRUS IN HOMOSEXUAL MEN [J].
COLLIER, AC ;
CHANDLER, SH ;
HANDSFIELD, HH ;
COREY, L ;
MCDOUGALL, JK .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :123-126
[7]  
Drew W L, 1993, Clin Diagn Virol, V1, P179
[8]   PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION [J].
DREW, WL ;
MINER, RC ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GULLETT, J ;
MEHALKO, SG ;
GORDON, SM ;
OWEN, WF ;
MATTHEWS, TR ;
BUHLES, WC ;
DEARMOND, B .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :716-719
[9]  
Enger C, 1997, Ophthalmic Epidemiol, V4, P41
[10]   Resistance of human cytomegalovirus to antiviral drugs [J].
Erice, A .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) :286-+